Erik Penser Bank has published an interview with Teodor Aastrup, Attana CEO

On Wednesday December 9th Johan Löchen, analyst at Erik Penser Bank, interviewed Teodor Aastrup, Attana CEO. The interview focuses on the ongoing rights issue with the subscription period December 3rd – December 17th. 

The interview is now published on Erik Penser Bank’s Youtube channel and can be seen here

For more information, please contact: 

Niklas Carlsson, COO 
niklas.carlsson@attana.com  
+46 (0)73 867 67 62 

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated. 

About Attana 
Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in-vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.se or contact sales@attana.com

Tags:

About Us

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com

Subscribe

Media

Media

Documents & Links